Dosage Forms - EU
Production Unit |
S.No |
Product Name |
Strength |
Pack Size |
Liquid Injectables |
1. |
Busulfan Injection |
6 mg/mL |
60 mg/10 mL |
2. |
Carboplatin Injection |
10 mg/mL |
50 mg/5 mL |
150 mg/15 mL |
450 mg/45 mL |
600 mg/60mL |
3. |
Cytarabine Injection |
100 mg/mL |
100 mg/1 mL |
500 mg/5 mL |
1g/10 mL |
2g/20 mL |
4. |
Docetaxel Injection Concentrate |
20 mg/mL |
20 mg/1 mL |
80 mg/4 mL |
120 mg/6 mL |
160 mg/8 mL |
180 mg/9 mL |
5. |
Etoposide Injection |
20 mg/mL |
100 mg/5 mL |
200 mg/10 mL |
500 mg/25 mL |
1g/50 mL |
6. |
Gemcitabine Injection (RTU) |
38 mg/mL |
200 mg/5.26 mL |
1g/26.3 mL |
2g/52.6 mL |
7. |
Irinotecan Hydrochloride Injection (Terminal Sterilization) |
20 mg/mL |
40 mg/2 mL |
100 mg/5 mL |
300 mg/15 mL |
500 mg/25 mL |
8. |
Oxaliplatin Injection |
5 mg/mL |
50 mg/10 mL |
100 mg/20 mL |
200 mg/40 mL |
9. |
Paclitaxel Injection |
6 mg/mL |
30 mg/5 mL |
100 mg/16.7 mL |
150 mg/25 mL |
300 mg/50 mL |
10. |
Pemetrexed Injection 25 mg/mL concentrate for solution for infusion |
25 mg/mL |
100 mg/4 mL |
500 mg/20 mL |
|
S.No |
Product Name |
Strength |
Pack Size |
Lyophilized Injectables |
11. |
Bendamustine Hydrochloride for Injection |
25 mg/vial |
25 mg/vial |
12. |
Bendamustine Hydrochloride for Injection |
100 mg/vial |
100 mg/vial |
13. |
Gemcitabine for Injection |
200 mg/vial |
200 mg/vial |
14. |
Gemcitabine for Injection |
1g/vial |
1g/vial |
15. |
Gemcitabine for Injection |
2g/vial |
2g/vial |
16. |
Pemetrexed for Injection |
100 mg/vial |
100 mg/vial |
17. |
Pemetrexed for Injection |
500 mg/vial |
500 mg/vial |
18 |
Bortezomib For Inj. |
3.5 mg/vial |
3.5 mg/vial |
19. |
Bortezomib For Inj. |
1.0 mg/vial |
1.0 mg/vial |
20. |
Bortezomib For Inj. |
2.5 mg/vial |
2.5 mg/vial |
Fresenius Kabi Oncology Ltd. do not intend to manufacture any product commercially until there is a valid IP. Listing of product shall not be construed in any way that Fresenius Kabi Oncology has violated any IP laws of the land.